BI 695501 DEMONSTRATES SIMILAR EFFICACY AND COMPARABLE SAFETY TO ADALIMUMAB REFERENCE PRODUCT IN PATIENTS WITH ACTIVE CROHN'S DISEASE: FINAL ANALYSIS OF THE PHASE III VOLTAIRE-CD STUDY

Stephen B Hanauer  1     Stefan Schreiber  2     Sigrid Balser  3     Ekkehard Brockstedt  4     Dorothy McCabe  5     Viktoria Moschetti     Bernd Liedert    
1 Feinberg School of Medicine, Northwestern University,Chicago,United States
2 Department Internal Medicine I, University Hospital Schleswig-Holstein,Kiel,Germany
3 Boehringer Ingelheim Pharma GmbH & Co. KG,Biberach an der Riss,Germany
4 Boehringer Ingelheim Pharma GmbH & Co. KG,Ingelheim am Rhein,Germany
5 Boehringer Ingelheim Pharm

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing